Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
Hand-out
Press Releases
January 7, 2025

Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements

TransCode shares to remain listed on Nasdaq

bradford

The Bradford Era

More by this Author
Local & Social